keyword
https://read.qxmd.com/read/37700596/influence-of-a-single-oral-dose-of-trazodone-on-intradermal-histamine-reactivity-in-clinically-healthy-dogs
#1
JOURNAL ARTICLE
Sarah Taylor Lewis, Robert Allen Kennis, Stuart Charles Clark-Price, Amelia Grant White
BACKGROUND: Drug interactions are significant considerations for intradermal testing (IDT). Trazodone (TRZ) is an anxiolytic and selective histaminergic (H1 ) antagonist with no interaction in human prick tests; however, interaction in canine IDT is unknown. HYPOTHESIS/OBJECTIVES: Trazodone will not adversely affect intradermal histamine reactions in dogs. ANIMALS: Fourteen nonanxious, nonatopic, healthy client-owned dogs were enrolled in this randomised, blinded, cross-over study...
September 12, 2023: Veterinary Dermatology
https://read.qxmd.com/read/37141665/chemotherapy-induced-phlebitis-experienced-by-women-with-breast-cancer-following-administration-of-epirubicin-using-a-volumetric-infusion-pump-an-observational-study
#2
JOURNAL ARTICLE
Natasha Williams, Edgar M Williams, Rosie Roberts
OBJECTIVE: To establish the incidence and severity of chemotherapy-induced phlebitis (CIP) following administration of epirubicin chemotherapy using a volumetric infusion pump (Hospira Plum 360), compared to a previous study of manual injection of epirubicin. Also the study aimed to gain insight into staff perceptions of ease of use and safety of infusion pump administration. METHODS: An observational study of women with breast cancer (n = 47) receiving epirubicin via volumetric infusion pump...
March 11, 2023: European Journal of Oncology Nursing: the Official Journal of European Oncology Nursing Society
https://read.qxmd.com/read/36989450/an-online-survey-among-us-patients-with-immune-mediated-conditions-attitudes-about-biosimilars
#3
JOURNAL ARTICLE
Allan Gibofsky, Gary Jacobson, Archie Franklin, Shannan O'Hara-Levi, Laurent Peyrin-Biroulet, Melissa McGrath, Dorothy McCabe
BACKGROUND: Few surveys about biosimilars have been conducted among US patients. OBJECTIVE: To evaluate attitudes about biosimilars among patients with rheumatoid arthritis (RA), psoriasis and/or psoriatic arthritis (PsO/A), and/or inflammatory bowel disease (IBD). METHODS: WebMD, LLC fielded a 16-item online survey to members of the US Dynata consumer panel meeting these criteria: aged 18 years or older; self-reported specialist diagnosis of RA, PsO/A, or IBD of at least 1 year; and not currently receiving an infliximab biosimilar...
April 2023: Journal of Managed Care & Specialty Pharmacy
https://read.qxmd.com/read/36445771/intravenous-physical-compatibility-of-heparin-sodium-and-furosemide
#4
JOURNAL ARTICLE
Briana Maktabi, Mitchell S Howard, Gabriella Baki, Mariann D Churchwell
Continuous infusions of heparin and furosemide are often required for hospitalized patients to treat cardiac-related disease states. Concomitant infusion of heparin and furosemide through the same intravenous line minimizes the need for multiple intravenous sites. For concomitant infusions to be administered, knowledge of the physical compatibility for intravenous medications is imperative for patient safety and administering medications to maximize their effectiveness. Currently, heparin and furosemide are listed as Y-site compatible, but precipitation was reported at a large academic medical center, which questions this compatibility...
2022: International Journal of Pharmaceutical Compounding
https://read.qxmd.com/read/35556092/bio-equivalence-of-potency-adjusted-approved-heparin-solutions-compared-to-a-newly-developed-heparin-solution
#5
JOURNAL ARTICLE
Debra Hoppensteadt, Walter Jeske, Ambar Farooqui, Ahmed Kouta, Omer Iqbal, Bulent Kantarcioglu, Roland Kraemer, Vinod Bansal, Jawed Fareed
INTRODUCTION: Porcine mucosal heparin solutions with a defined potency adjusted concentrations are widely used for the anticoagulation in medical, surgical and interventional indications. Recently, Sintetica has developed a 20.000 IU (48 ml, 416 IU/ml) solution. The active pharmaceutical ingredient used is a porcine mucosal origin with a specific activity of 194 U/mg. The purpose of this investigation is to compare the Sintetica heparin solution with other commercially available potency adjusted heparin solutions such as Fresenius, Roche, Hospira and Medefil heparins to demonstrate their bio-equivalence in various biological assays...
May 2022: FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology
https://read.qxmd.com/read/34863171/respiratory-obstruction-due-to-tonsillar-lymphoglandular-polyp-in-a-brachycephalic-dog-a-case-report
#6
JOURNAL ARTICLE
Leah Gabriel, Yazdan Aryazand, Nicole Buote
BACKGROUND: Respiratory distress is one of the most common afflictions of brachycephalic dogs. Dogs in respiratory distress usually present to the emergency service with a constellation of clinical signs including but not limited to: stertorous breathing, dyspnea, gagging, cyanotic mucus membranes, hyperthermia, and commonly a history of gastrointestinal signs. While Brachycephalic Obstructive Airway Syndrome is the most common cause of respiratory distress in dogs with brachycephalic conformation, any condition eliciting an inflammatory response in the oropharynx, can result in obstruction...
December 4, 2021: BMC Veterinary Research
https://read.qxmd.com/read/34595956/association-of-dyskalemias-with-short-term-health-care-utilization-in-patients-with-advanced-ckd
#7
JOURNAL ARTICLE
Ankur A Dashputre, Justin Gatwood, Keiichi Sumida, Fridtjof Thomas, Oguz Akbilgic, Praveen K Potukuchi, Yoshitsugu Obi, Miklos Z Molnar, Elani Streja, Kamyar Kalantar-Zadeh, Csaba P Kovesdy
BACKGROUND: Patients with advanced chronic kidney disease (CKD) are at high risk for dyskalemias, which may induce arrhythmias that require immediate emergent or hospital care. The association of dyskalemias with short-term hospital/emergency room (ER) visits in advanced CKD is understudied. OBJECTIVE: To assess the association of dyskalemias with short-term hospital/ER visits in an advanced CKD population. METHODS: From among 102,477 US veterans transitioning to dialysis from 2007 to 2015, we identified 21,366 patients with 2 predialysis outpatient eGFR < 30 ml/min/1...
October 2021: Journal of Managed Care & Specialty Pharmacy
https://read.qxmd.com/read/34505631/the-clearsight-system-for-postoperative-arterial-blood-pressure-monitoring-after-carotid-endarterectomy-a-validation-study
#8
JOURNAL ARTICLE
L M M Fassaert, J D J Plate, J Westerink, R V Immink, G J de Borst
BACKGROUND: The majority of postoperative events in patients undergoing carotid endarterectomy(CEA) are of hemodynamic origin, requiring preventive strict postoperative arterial blood pressure(BP) control. This study aimed to assess whether BP monitoring with non-invasive beat-to-beat ClearSight finger BP(BPCS) can replace invasive beat-to-beat radial artery BP(BPRAD) in the postoperative phase. METHODS: Single-centre clinical validation study using a pre-specified study protocol...
September 10, 2021: American Journal of Hypertension
https://read.qxmd.com/read/34390244/physical-compatibility-of-normosol-r-with-critical-care-medications-used-in-patients-with-covid-19-during-simulated-y-site-administration
#9
JOURNAL ARTICLE
Amanda A Holyk, Alexandra H Lindner, Scott E Lindner, Brian W Shippert
PURPOSE: Guidelines from the National Institutes of Health support the use of balanced crystalloid solutions such as Normosol-R (Hospira, Lake Forest, IL) for patients with coronavirus disease 2019 (COVID-19). However, their clinical utility is hindered by a lack of Y-site compatibility data that is essential for use in patients with limited intravenous access. The objective of this study was to determine the physical compatibility of selected intensive care unit medications with Normosol-R...
January 1, 2022: American Journal of Health-system Pharmacy: AJHP
https://read.qxmd.com/read/34269041/liposomal-bupivacaine-use-in-exploratory-lingual-nerve-microsurgery-does-liposomal-bupivacaine-use-decrease-postoperative-pain-and-opioid-consumption-compared-to-bupivacaine-hydrochloride-a-pilot-study
#10
JOURNAL ARTICLE
Douglas Jacobus, Sofia Mehr, Vincent Ziccardi
OBJECTIVES: The purpose of this study was to determine if liposomal bupivacaine 1.3% (LB), Exparel (Pacira Pharmaceuticals), is more effective than bupivacaine hydrochloride 0.25% (BH), Marcaine (Hospira), in reducing postoperative pain and opioid consumption in patients undergoing exploratory lingual nerve microsurgery. The investigators hypothesized that patients who received LB would have a greater reduction in acute postoperative pain, and therefore, a reduction in total opioid use over 72 hours postoperatively...
September 9, 2021: Quintessence International
https://read.qxmd.com/read/33880314/rapid-blood-transfusion-the-importance-of-hemodilution-and-needleless-connectors
#11
JOURNAL ARTICLE
Mark A Burbridge, Anil K Panigrahi, Sarah A Stone, Richard A Jaffe, John Brock-Utne
INTRODUCTION:  Large-bore cannulas are critical to administering IV fluids and blood products during resuscitation and treatment of hemorrhage. Although catheter flow rates for crystalloid solutions are well defined, rapid administration of blood products is poorly characterized. In this in vitro study, we examined the effects of hemodilution and needleless connectors on red blood cell (RBC) flow rates. METHODS:  To determine RBC flow rates through large-bore cannulae, a crystalloid solution (Normosol®, Hospira, Lake Forest, IL) or RBC units were warmed and delivered under pressure (360 mmHg) using a Level 1 H-1200 Fast Flow Fluid Warmer (Smiths Medical, St...
March 19, 2021: Curēus
https://read.qxmd.com/read/32734207/long-term-safety-of-epoetin-alfa-epbx-for-the-treatment-of-anemia-in-eskd-pooled-analyses-of-randomized-and-open-label-studies
#12
JOURNAL ARTICLE
Jay B Wish, Marcelo G Rocha, Nancy E Martin, Christian Russel D Reyes, Steven Fishbane, Mark T Smith, George Nassar
Rationale & Objective: Epoetin alfa-epbx is a biosimilar to the reference product, epoetin alfa. We compare the safety of epoetin alfa-epbx versus epoetin alfa based on a pooled analysis of findings from 2 randomized, double-blind, comparative clinical studies, and report new data for the long-term safety of epoetin alfa-epbx. Study Design: Pooled analyses of previously conducted studies. Setting & Participants: Hemodialysis patients with anemia...
September 2019: Kidney medicine
https://read.qxmd.com/read/32682483/dexmedetomidine-for-reduction-of-atrial-fibrillation-and-delirium-after-cardiac-surgery-decade-a-randomised-placebo-controlled-trial
#13
RANDOMIZED CONTROLLED TRIAL
Alparslan Turan, Andra Duncan, Steve Leung, Nika Karimi, Jonathan Fang, Guangmei Mao, Jennifer Hargrave, Marc Gillinov, Carlos Trombetta, Sabry Ayad, Manal Hassan, Andrew Feider, Kimberly Howard-Quijano, Kurt Ruetzler, Daniel I Sessler
BACKGROUND: Atrial fibrillation and delirium are common consequences of cardiac surgery. Dexmedetomidine has unique properties as sedative agent and might reduce the risk of each complication. This study coprimarily aimed to establish whether dexmedetomidine reduces the incidence of new-onset atrial fibrillation and the incidence of delirium. METHODS: A randomised, placebo-controlled trial was done at six academic hospitals in the USA. Patients who had had cardiac surgery with cardiopulmonary bypass were enrolled...
July 18, 2020: Lancet
https://read.qxmd.com/read/32599408/comparative-analysis-of-docetaxel-physical-and-chemical-characterisation-of-taxot%C3%A3-re%C3%A2-and-generics
#14
JOURNAL ARTICLE
Roy Pétronille, Do Bernard, Le Guyader Guillaume, Viellard Victoire, Fleury Thomas, Conq Jérôme, Da Costa Eloïse, Pierron Gérard, Souquere Sylvie, Solgadi Audrey, Lemare François, Delaloge Suzette, Paul Muriel, Annereau Maxime
Several cases of fatal enterocolitis have been described in association with the use of docetaxel (DTX), and this increase in adverse events has been concomitant with a change in formulation. Indeed in 2010, a new DTX-based presentation has been introduced in the form of a single ready-to-use vial by Sanofi-Aventis, presentation also used for generics. In this study, different available formulations were compared (Sanofi 2 vials, Sanofi 1 vial, Accord Healthcare, Kabi, Hospira) in terms of composition compliance with control specifications and simulated micelle behaviour to try to determine what could be the potential causes of this problem...
June 26, 2020: European Journal of Cancer
https://read.qxmd.com/read/31723996/ibrutinib-and-rituximab-provides-superior-clinical-outcome-compared-to-fcr-in-younger-patients-with-chronic-lymphocytic-leukemia-cll-extended-follow-up-from-the-e1912-trial
#15
JOURNAL ARTICLE
Tait D Shanafelt, Victoria Wang, Neil E Kay, Curtis A Hanson, Susan M O'Brien, Jacqueline C Barrientos, Diane F Jelinek, Esteban Braggio, Jose F Leis, Cong Christina Zhang, Steven Coutre, Paul M Barr, Amanda F Cashen, Anthony R Mato, Avina Singh, Michael P Mullane, Richard F Little, Harry P Erba, Richard M Stone, Mark Litzow, Martin S Tallman
Shanafelt: Pharmacyclics: Research Funding; Patent: Patents & Royalties: US14/292,075 on green tea extract epigallocatechin gallate in combination with chemotherapy for chronic lymphocytic leukemia; Polyphenon E International: Research Funding; Merck: Research Funding; Abbvie: Research Funding; Genentech: Research Funding; Celgene: Research Funding; Glaxo-SmithKline: Research Funding; Hospira: Research Funding; Cephalon: Research Funding. Kay:MorphoSys: Other: Data Safety Monitoring Board; Infinity Pharmaceuticals: Other: DSMB; Celgene: Other: Data Safety Monitoring Board; Agios: Other: DSMB...
November 13, 2019: Blood
https://read.qxmd.com/read/31634551/comparative-in-vitro-antimicrobial-potency-stability-colouration-and-dissolution-time-of-generics-versus-innovator-of-meropenem-in-europe
#16
JOURNAL ARTICLE
Isabelle K Delattre, Caroline Briquet, Pierre Wallemacq, Paul M Tulkens, Françoise Van Bambeke
Meropenem generics are often imposed on prescribers, however scarce information is available on key properties such as antimicrobial potency, stability and colouration in solution, and dissolution time. This study aimed to generate comparative information for products available in Europe. The originator (ASTRA) and four generics (HOSPIRA, SANDOZ, FRESENIUS and AUROVIT) were compared for: (i) MICs against Pseudomonas aeruginosa clinical isolates (range, 0.125-191 mg/L); (ii) colouration (visual and photometry) and stability of concentrated solutions for prolonged or continuous infusion and maintained at 25-37 °C for up to 8 h (acceptable limit, ≥90% of original concentration); and (iii) dissolution time of concentrated solutions (50 mg/mL [for bolus administration]: turbidimetry and nursing personnel assessment)...
January 2020: International Journal of Antimicrobial Agents
https://read.qxmd.com/read/31205333/impact-of-implementing-smart-infusion-pumps-in-an-intensive-care-unit-in-mexico-a-pre-post-cost-analysis-based-on-intravenous-solutions-consumption
#17
JOURNAL ARTICLE
Erika Palacios Rosas, Isaac F Soria-Cedillo, Fabiola Puértolas-Balint, Rebecca Ibarra-Pérez, Sergio E Zamora-Gómez, Elizabeth Lozano-Cruz, Marcos A Amezcua-Gutiérrez, Lucila I Castro-Pastrana
Background: The use of smart pump technology has shown to be profitable in the intensive care unit (ICU) because it avoids costs from prevented medication errors and allows for savings on disposables and medications by establishing standardized concentrations and dosing units. Objective : The objective of the study is to evaluate the economic impact of the implementation of smart infusion pumps in the consumption of intravenous (IV) solutions in an ICU. Methods: A retrospective observational study was conducted with a pre-post design...
June 2019: Hospital Pharmacy
https://read.qxmd.com/read/30633054/speeding-the-detection-of-vessel-cannulation-an-in-vitro-stimulation-study
#18
JOURNAL ARTICLE
Matthew K Muffly, Andrew Ku, David R Drover, Samuel Rodriguez, Thomas J Caruso, Anne Ku, Ban C H Tsui
BACKGROUND: Some practitioners "prime" small IV angiocatheter needles with 0.9% sodium chloride-claiming this modification speeds visual detection of blood in the angiocatheter flash chamber on vessel cannulation. METHODS: We compared the time required for human blood to travel the length of saline-primed and saline-unprimed 24- and 22-gauge angiocatheter needles (Introcan Safety IV Catheter; B. Braun, Bethlehem, PA). A syringe pump (Medfusion 4000, Cary, NC) advanced each angiocatheter needle through the silicone membrane of an IV tubing "t-piece" (Microbore Extension Set, 5 Inch; Hospira, Lake Forest, IL) filled with freshly donated human blood...
January 8, 2019: Anesthesia and Analgesia
https://read.qxmd.com/read/30298233/systematic-review-and-meta-analysis-of-short-versus-long-acting-granulocyte-colony-stimulating-factors-for-reduction-of-chemotherapy-induced-febrile-neutropenia
#19
COMPARATIVE STUDY
Paul Cornes, Pere Gascon, Stephen Chan, Khalid Hameed, Catherine R Mitchell, Polly Field, Mark Latymer, Luiz H Arantes
INTRODUCTION: Short- and long-acting granulocyte-colony stimulating factors (G-CSFs) are approved for the reduction of febrile neutropenia. A systematic literature review was performed to identify randomized controlled trials (RCTs) and non-RCTs reporting the use of G-CSFs following chemotherapy treatment. METHODS: Medline® /Medline in-process, Embase® , and the Cochrane Library were searched for studies published between January 2003 and June 2016. A hand-search of relevant conference proceedings was conducted for meetings held between 2012 and 2016...
November 2018: Advances in Therapy
https://read.qxmd.com/read/29205444/switching-from-infliximab-innovator-to-biosimilar-in-patients-with-inflammatory-bowel-disease-a-12-month-multicentre-observational-prospective-cohort-study
#20
MULTICENTER STUDY
E M H Schmitz, P J Boekema, J W A Straathof, D C van Renswouw, L Brunsveld, V Scharnhorst, M E C van de Poll, M A C Broeren, L J J Derijks
BACKGROUND: Infliximab biosimilars have become available for treatment of inflammatory bowel disease (IBD). However, data showing long-term safety and effectiveness of biosimilars in IBD patients are limited. AIM: To study prospectively the switch from infliximab innovator to biosimilar in an IBD cohort with 12 months follow-up to evaluate safety and effectiveness. METHODS: Adult IBD patients from two hospitals treated with infliximab innovator (Remicade; Janssen Biotech,  Horsham ,  Pennsylvania, USA) were switched to infliximab biosimilar (Inflectra; Hospira, Lake Forest, Illinois, USA) as part of routine care, but in a controlled setting...
February 2018: Alimentary Pharmacology & Therapeutics
keyword
keyword
14788
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.